CMC Jumpstart™
No long-term commitments | Assess the productivity of your GOI | Prepare for the clinic
Take the next step
Offering CMC peace of mind before IND
In an industry with finite resources where every decision counts, CGT developers need an efficient and trusted process to evaluate the feasibility of their vector platform. CMC Jumpstart is here to help you understand your transgene, get visibility into your platform's performance and CMC limitations, and secure your path to IND.
Don't gamble with your vector... or your business
Before investing resources to begin clinical work, get representative scale-down data to understand your platform's performance and any limitations that could directly impact cGMP or commercial viability. No long-term commitment required.
CMC Jumpstart Benefits:
- One of the most experienced CGT CDMOs in the world. A Center of Excellence that has produced 5 commercial vectors, 4 commercial cell therapies, 400+ viral vector GMP batches and 30+ clinical trials.
- IND peace of mind. Receive detailed data and performance results on your platform process and its feasibility for long-term success.
- Bring your GOI and we'll do the rest. We provide packaging plasmids, backbone transfer plasmids (upon request), and process and cell line development
- Proven and reliable AAV and LVV platforms, using adherent and suspension techniques.
- In-house analytics and fully qualified scale-down models provide fully representative data.
Built with proven proprietary platform processes
Our templated adeno-associated viral vector platform.
Learn moreOur templated lentiviral vector platform.
Learn more